Skip to main content
NEU Senior Regional Support Officer
Patents: how the profit machine costs lives
Despite miraculous trial results showing new treatment could halt transmission, corporate greed and patent laws condemn millions to preventable infection and death, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
LINING THEIR POCKETS: Gilead Sciences HQ in Foster City, California; (insert) Descovy used for HIV prevention through pre-exposure prophylaxis [(L to R) Coolcaesar/CC - EEJCC/CC]

DECIDING a particular year when a scientific discovery or advance took place is often an arbitrary decision. Archimedes is said to have leapt from his bathtub and shouted “Eureka!” when he realised that the volume of any object, no matter how complicated, could be found by placing the object in water and measuring the volume of water it displaces.

But even that eureka moment is of dubious authenticity. It is rare for scientific research to advance in a glorious instant of revelation.

So when the journal Science named the HIV/AIDS drug lenacapavir as its “breakthrough of the year,” it shouldn’t be surprising that its story began far earlier.

The 95th Anniversary Appeal
Support the Morning Star
You have reached the free limit.
Subscribe to continue reading.
Similar stories
TRAILBLAZING RESEARCH: Dr Aggrey Burke in 2022; Jamaican immigrants met by the Colonial Office officials as they disembark from the Empire Windrush one in four will commit suicide / Windrush pic: Whispyhistory/CC
Obituary / 31 December 2025
31 December 2025

1943-2025: How one man’s unfinished work reveals the lethal lie of ‘colour-blind’ medicine

COST CONTROL MODE: Health Secretary Wes Streeting during a visit to NHS National Operations Centre in London on July 25 2025
Features / 18 September 2025
18 September 2025

Politicians who continue to welcome contracts with US companies without considering the risks and consequences of total dependency in the years to come are undermining the raison d’etre of the NHS, argues Dr JOHN PUNTIS

POISON: Centivax workers study antivenom to counteract the bites of various snakes at the company lab in San Francisco
Science and Society / 7 May 2025
7 May 2025

A maverick’s self-inflicted snake bites could unlock breakthrough treatments – but they also reveal deeper tensions between noble scientific curiosity and cold corporate callousness, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT

Former President Jair Bolsonaro attends a rally on Copacaban
World / 24 March 2025
24 March 2025